Improving Uptake of Biomarker Testing and Precision Medicine in Cancer Care

Key opinion leaders in the field of cancer management discuss resistance to the uptake of biomarker testing and precision medicine, with deference to the community setting.

Related Videos
Expert on breast cancer
Experts on BTC
Experts on BTC
In this sixth episode of OncChats: Traveling Through the Lung Cancer Treatment Paradigm, Aaron Franke, MD, discusses the consideration of adverse effects related to treatment with TKIs patients in non–small cell lung cancer.
Expert on CSCC
Experts on CSCC
Experts on AML
Expert on AML
Experts on CRC
Expert on CRC
Related Content